Russell Investments Group
MRNS

Russell Investments Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Russell Investments Group’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,572
Closed -$4.53K – 3847
2024
Q3 		$4.53K Sell
2,572
-1,915
-43% -$2.67K ﹤0.01% 3240
2024
Q2 		$5.25K Buy
+4,487
New +$11.2K ﹤0.01% 3199
2023
Q4 		– Sell
-38
Closed -$306 – 3337
2023
Q3 		$306 Buy
+38
New +$316 ﹤0.01% 3444
2020
Q4 		– Sell
-2,605
Closed -$32K – 3231
2020
Q3 		$32K Sell
2,605
-1
-0% -$9 ﹤0.01% 3111
2020
Q2 		$26K Buy
+2,606
New +$24K ﹤0.01% 3039

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group's MRNS Position: Q4 2024 in Review

Russell Investments Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 2,572 shares — an estimated $4.53K sold.

Russell Investments Group first reported a position in MRNS in Q2 2020 and held it in 5 quarters. The position peaked at $32K in Q3 2020. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Russell Investments Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 2,572 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $4.53K.
  • Russell Investments Group first reported a position in Marinus Pharmaceuticals, Inc in Q2 2020 and held it in 5 quarters.
  • Russell Investments Group's Marinus Pharmaceuticals, Inc position peaked at $32K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.